Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer

King Faisal Specialist Hospital & Research Center

Status: Completed

Conditions: Breast Cancer

Treatments: Drug: Doxorubicin, Docetaxel, Cisplatin

Study type: Interventional

Funder types: Other

Identifiers

NCT00538525

RAC#2011-022

Details and patient eligibility

About

Phase II study of neoadjuvant chemotherapy with Doxorubicin followed by Docetaxel-Cisplatin in locally advanced breast cancer

Enrollment: 10 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with locally advanced breast cancer

Exclusion criteria

• Patients with metastatic breast cancer

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

Arm 1

Active Comparator group

Description:

Doxorubicin, Docetaxel, Cisplatin

Treatment:

Drug: Doxorubicin, Docetaxel, Cisplatin